| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.9 |
| mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.0085 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.9 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |